Thus, the DOX-treated Ptpro–/– mice, compared with WT controls, display more dramatically severe cognitive deficits that correlate with alterations in synaptic plasticity of CA3 hippocampal neurons. The gene discussed is PTPRO; the disease is Cognitive impairment.